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Abstract
Background: The endometrium is commonly infected with bacteria leading to severe disease of the
uterus in cattle and humans. The endometrial epithelium is the first line of defence for this mucosal surface
against bacteria and Toll-like receptors (TLRs) are a critical component of the innate immune system for
detection of pathogen associated molecular patterns (PAMPs). Antimicrobial peptides, acute phase
proteins and Mucin-1 (MUC-1) also provide non-specific defences against microbes on mucosal surfaces.
The present study examined the expression of innate immune defences in the bovine endometrium and
tested the hypothesis that endometrial epithelial cells express functional receptors of the TLR family and
the non-specific effector molecules for defence against bacteria.
Methods: Bovine endometrial tissue and purified populations of primary epithelial and stromal cells were
examined using RT-PCR for gene expression of TLRs, antimicrobial peptides and MUC-1. Functional
responses were tested by evaluating the secretion of prostaglandin E2 and acute phase proteins when cells
were treated with bacterial PAMPs such as bacterial lipopolysaccharide (LPS) and lipoproteins.
Results:  The endometrium expressed TLRs 1 to 10, whilst purified populations of epithelial cells
expressed TLRs 1 to 7 and 9, and stromal cells expressed TLRs 1 to 4, 6, 7, 9 and 10. The TLRs appear to
be functional as epithelial cells secreted prostaglandin E2 in response to bacterial PAMPs. In addition, the
epithelial cells expressed antimicrobial peptides, such as Tracheal and Lingual Antimicrobial Peptides (TAP
and LAP) and MUC-1, which were upregulated when the cells were treated with LPS. However, the
epithelial cells did not express appreciable amounts of the acute phase proteins haptoglobin or serum
amyloid A.
Conclusion: Epithelial cells have an essential role in the orchestration of innate immune defence of the
bovine endometrium and are likely to be the key to prevention of endometrial infection with bacteria.
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Background
Microbial infection of the female genital tract is an impor-
tant cause of disease, infertility and mortality in mam-
mals, particularly cattle and humans. Bos taurus is a
biologically relevant model to study female genital tract
disease because infections are ubiquitous after parturi-
tion, often leading to uterine disease. Up to 40% of ani-
mals develop clinical metritis within 2 weeks of
parturition and endometritis persists for at least 3 weeks
in about 20% of cattle [1,2]. The microbes most com-
monly associated with postpartum uterine disease are
Escherichia coli, Arcanobacterium pyogenes and bovine her-
pesvirus 4 (BoHV-4) [2-4]. E. coli infection paves the way
for subsequent infection with A. pyogenes and activates
BoHV-4 replication [5,6]. The first line of defence against
these infections in the female genital tract is the
endometrium, which is a mucosa comprising of a layer of
single columnar epithelial cells overlying a stroma that
contains blood vessels and immune cells as well as
endometrial stromal cells. The initial defence of the
endometrium against microbes is dependent on innate
immune systems, including Toll-like receptors (TLRs),
antimicrobial peptides (AMPs), and acute phase proteins
(APPs) [7,8]. Furthermore, the immune defence of the
endometrium is regulated by the ovarian steroids, oestra-
diol and progesterone [9]. Bos taurus endometrium
presents an advantage over human or mouse models for
studying innate immunity because it is possible to obtain
purified populations of epithelial or stromal cells that are
not contaminated by other immune cells [10].
TLRs recognise pathogen associated molecular patterns
(PAMPs), and 10 members of the receptor family are
widely expressed in the mammalian genome [11]. TLR1,
TLR2, and TLR6 recognise bacterial lipids such as lipotei-
choic acid (LTA), whereas TLR3, TLR7, TLR8, and TLR9
recognize nucleic acids, often from viruses, although TLR9
also recognises bacterial DNA. TLR4 recognizes lipopoly-
saccharide (LPS) from Gram-negative bacteria such as E.
coli, and TLR5 binds flagellin, but the ligand for TLR10 is
still not known. The expression of TLRs in the
endometrium has been examined in humans [12,13].
However, in cattle, only TLR4 has been studied in detail in
endometrial cells, where LPS treatment was characterised
by the secretion of prostaglandin E2 [14].
AMPs are an ancient component of the immune system,
of which β-defensins are the main family, and are particu-
larly important for mucosal immunity [15]. Indeed, the
first mammalian β-defensin, Tracheal Antimicrobial Pep-
tide (TAP), was identified in cattle. The Bos taurus genome
sequence has been exploited to expand the AMP family to
57 putative β-defensin genes – the most in any mammal
[16]. In a study screening several bovine tissues, the uterus
was found to express genes encoding Lingual Antimicro-
bial Peptide (LAP), Bovine neutrophil β-defensins
(BNBD4, DEFB5), and novel bovine β-defensins (BBD19,
BBD123 and BBD124) [17]. However, such uterine sam-
ples also contain a complex range of cell types, so it is not
clear if AMPs are expressed by endometrial cells and have
a role in the immune defence of the endometrium.
Acute phase proteins (APPs) such as haptoglobin and
serum amyloid A provide non-specific protection against
microbes [18]. These APPs are usually produced by the
liver, but localised expression has been found in the geni-
tal tract of rodents and expression was regulated by the sex
steroids [19,20]. Mucin-1 (MUC-1) is an epithelial cell
glycosylated transmembrane protein that may also have a
role in microbial defence of the endometrium [21].
Although MUC-1 expression has not been evaluated in
the bovine uterus, it is expressed by epithelial cells of the
human and ovine endometrium [22,23].
Our central paradigm is that the endocrine cells of the
endometrium play the key role in the defence of the
uterus against microbial infection. The present study
tested the hypothesis that endometrial epithelial cells
express functional receptors of the TLR family and the
non-specific effector molecules for defence against bacte-
ria. The first objective was to establish if bovine
endometrium expresses TLRs. The next question was
which endometrial cells express functional receptors of
the TLR family and the non-specific effector molecules
such as AMPs, APPs, and MUC-1 for defence against bac-
teria.
Methods
Tissues and cells
Uteri from postpubertal non-pregnant cattle were col-
lected at a local abattoir immediately after slaughter and
kept on ice until further processing in the laboratory.
These animals had no evidence of genital disease based on
visual inspection and attempted culture of bacteria using
standard microbiological techniques. The physiological
stage of the reproductive cycle for each genital tract was
determined by observation of the ovarian morphology
[24]. Tracts with an early corpus luteum (Stage 1) were
selected for endometrial tissue and cell culture.
Endometrium was carefully dissected free from the under-
lying tissue and immediately used for cell isolation or put
in RNAlater (Qiagen, Crawley, UK) for isolation of mRNA
to examine gene expression.
Cell isolation was performed as previously described
using only the endometrium from the horn ipsilateral to
the corpus luteum [14]. Briefly, tissue was digested in 25
ml sterile filtered digestive solution, which was made by
dissolving 50 mg trypsin III (Roche, Lewes, UK), 50 mg
collagenase II (Sigma, Poole, UK), 100 mg BSA (Sigma),Reproductive Biology and Endocrinology 2008, 6:53 http://www.rbej.com/content/6/1/53
Page 3 of 12
(page number not for citation purposes)
and 10 mg DNase I (Sigma) in 100 ml phenol-red-free
Hanks Balanced Salt Solution (HBSS; Sigma). After a 1.5-
h incubation in a shaking water bath at 37°C, the cell sus-
pension was filtered through a 40-μm mesh (Fisher Scien-
tific, Loughborough, UK) to remove undigested material,
and the filtrate was resuspended in phenol-red-free HBSS
containing 10% fetal bovine serum (FBS; Sigma) and 3
μg/ml trypsin inhibitor (Sigma) (washing medium). The
suspension was centrifuged at 100 × g for 10 min and,
after two further washes in washing medium, the cells
were resuspended in RPMI 1640 medium (Sigma) con-
taining 10% fetal bovine serum (PAA laboratories), 50
IU/ml penicillin, 50 μg/ml streptomycin, and 2.5 μg/ml
amphotericin B (Sigma). The cells were plated at a density
of 1 × 105 cells in 2 ml per well using 24-well plates
(Nunc, Rochester, NY, USA). To obtain separate stromal
and epithelial cell populations, the cell suspension was
removed 18 h after plating, which allowed selective
attachment of stromal cells, and the removed cell suspen-
sion was then replated and incubated allowing epithelial
cells to adhere. Stromal and epithelial cell populations
were distinguished by cell morphology and the purity was
greater than 95% as determined by microscopy and the
differential production of prostaglandins – stromal cells
do not produce prostaglandin F2α [14]. The culture media
was changed every 48 h until the cells reached confluence.
All cultures were maintained at 37°C, 5% CO2 in air, in a
humidified incubator.
Purified populations of stromal and epithelial cells were
collected and stored immediately in RNAlater for mRNA
isolation to examine gene expression. To examine if the
TLRs were function, 90% confluent stromal and epithelial
cells were challenged for 24 h with bacterial PAMPs at
concentrations recommended by the manufacture. The
PAMPs were 1 μg/ml O55:B5 LPS (Sigma) or 1 μg/ml
ultrapurified O111:B4 LPS (InvivoGen, San Diego, CA,
USA) for TLR4; 1 μg/ml Pam3CSK4 synthetic bacterial
lipoprotein for TLR2 and TLR1 (InvivoGen); 1 μg/ml puri-
fied lipoteichoic acid from Staphylococcus aureus for TLR2
(LTA, InvivoGen); or, 5 μg/ml LPS-free DNA from E. coli
for TLR9 (DNA, InvivoGen). The culture supernatants
were harvested and frozen at -20°C until used to measure
prostaglandin E2  as previously described [14]. Briefly,
samples were diluted in 0.05 M Tris buffer containing
0.1% gelatin and 0.01% sodium azide. Standards and tri-
tiated tracers for the prostaglandin were purchased from
Sigma and Amersham International PLC (Amersham, Lit-
tle Chalfont, Buckinghamshire, UK), respectively. The
antiserum was a generous gift from Prof. N. L. Poyser
(University of Edinburgh, Edinburgh, UK), the limit of
detection was 2 pg/tube, and intra-assay and inter-assay
coefficients of variation were 4.4 and 7.8%, respectively.
The effect of the PAMPs on cell survival was evaluated by
counting the number of live epithelial and stromal cell
using a haemocytometer and the Trypan Blue exclusion
method.
To examine AMP, MUC-1  and APP expression stromal
and epithelial cells were collected and stored immediately
in RNAlater for mRNA isolation. To test if these molecules
have a role in the endometrial response to bacteria, the
cells were also treated for 24 h with 1 μg/ml O55:B5 LPS
(Sigma), progesterone (Sigma), or oestradiol (Sigma), as
indicated in Results.
Toll-like receptors
Total RNA was isolated with the RNeasy Mini kit (Qiagen)
from the samples stored in RNAlater, and DNase treated
with RQ1 RNase-free DNase (Promega, Madison, USA).
The RNA quality and quantity was determined by spectro-
photometry using a NanoDrop-1000 (Labtech Int. Ltd,
Ringmer, UK) and 1 μg reverse transcribed using Super-
Script II RT (Invitrogen, Paisley, UK) to synthesise first
strand cDNA, according to the manufacturers' instruc-
tions.
Intron-spanning gene-specific primers for real-time
polymerase chain reaction (RT-PCR) were designed for
TLRs 1 to 10 coding sequences published in the National
Center for Biotechnology Information database (NCBI,
Bethesda, MD, USA) with the aid of Primer3 software
[25], and purchased from MWG (Ebersberg, Germany).
Details of the PCR primer sequences are provided in Table
1, and each product was sequenced to confirm specificity.
Amplification of cDNA was performed using the follow-
ing conditions: an initial denaturation at 94°C for 5 min;
followed by 38 cycles of 94°C for 30 sec, 55–56°C
(depending on primer pair TM) for 30 sec and 72°C for 30
sec; with a final extension at 72°C for 5 min. Resulting
PCR amplicons were separated on 2% agarose gels to con-
firm the amplification of distinct bands and to assess the
expression of each gene.
Antimicrobial peptides
Intron-spanning gene-specific primers for RT-PCR were
designed, using the Vector NTI Advance™ software pack-
age (Invitrogen, Paisley, UK) and commercially synthe-
sised (Invitrogen) for the following AMPs: LAP,  TAP,
BNBD4,  DEFB5, and BBD119,  BBD120,  BBD122,
BBD122a, BBD123, BBD124, BBD142, as previously
described in detail [17]. The AMPs selected were chosen
because they had been identified previously in RNA
extracted from a homogenate of uterine tissue [17]. For
those gene transcripts identified in the endometrial cells
in the present study, quantitative PCR was performed.
Each reaction was carried out in duplicate in a total vol-
ume of 25 μl with 2 μl of cDNA (20 ng/μl), 12.5 μl 2 ×
PCR master mix (Stratagene Corp., La Jolla, CA, USA), and
10.5 μl primer/H2O. Optimal concentrations of primersReproductive Biology and Endocrinology 2008, 6:53 http://www.rbej.com/content/6/1/53
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were determined by titrating 100, 300 and 900 nM final
concentrations of the forward and reverse primers. Real
time qRT-PCR was performed using an MX3000P® quanti-
tative PCR system (Stratagene Corp.) with the following
cycling parameters: 95°C for 10 min followed by 40 cycles
of 95°C for 30 sec, 60°C for 1 min and 72°C for 30 sec
followed by amplicon dissociation. Resulting PCR ampli-
cons were separated on 2% agarose gels to confirm the
amplification of distinct bands and to assess the expres-
sion of each gene. The 2-ΔΔCt method was used to deter-
mine median fold changes in gene expression.
MUC-1
Total RNA was isolated as above, with intermediate on-
column DnaseI digestion step (Qiagen, UK) and 1 μg RNA
was reverse transcribed using random decamer primers
(RETROscript™, Ambion, UK). Gene specific primer pairs
were designed (Beacon Design 2.0, Premier Biosoft, USA)
for  MUC-1  (sense 5'-TGTGGTGGTAGAATTAACTC-3';
antisense 5'-ACTAACTCCGCTGATGG-3'; 120 bp) and β-
ACTIN  (sense 5'-ATCGGCAATGAGCGGTTCC-3'; anti-
sense 5'-GTGTTGGCGTAGAGGTCCTTG-3'; 143 bp) as a
reference amplicon. Amplification reactions were pre-
pared in a volume of 20 μL by adding 10 μL of SYBR-
Green Supermix 2× containing the Thermo-Start® DNA
Polymerase (ABgene), 2.5 μL of each primer (4 μM) and 5
μL of serial dilutions of cDNA. RT-PCR amplifications
were done in triplicate in 96-well optical reaction plates
and run in the BioRad IQ iCycler; genomic DNA and RNA
were used as positive and negative controls, respectively.
Plates were heated first to 95°C for 15 min to activate the
Thermo-Start® DNA Polymerase enzyme and run for 50
cycles of 15 sec at 95°C, 30 sec at the optimal annealing
temperature for each primer pair and 30 sec at 72°C, fol-
lowed by 1 cycle of annealing at 55°C for 30 sec and 1
cycle of denaturation at 95°C for 30 sec. To obtain the
melting curves for each sample a final step of 40 cycles was
performed for 10s at 53°C, increasing the set point tem-
perature by 1°C per cycle up to a maximum temperature
of 94°C. No amplicons were obtained using RNA directly
in the PCR reaction. Relative quantification of gene
expression data was determined from threshold cycle (Tc)
values for each sample. Serial dilutions of cDNA were
used to plot a calibration curve, and gene expression levels
quantified by plotting Tc values on the curve. Expression
levels were normalised with values obtained for the inter-
nal reference gene, and fold expression calculated as a
ratio of transcript levels between treated and control sam-
ples.
Acute phase proteins
The concentration of haptoglobin was determined using a
haptoglobin-haemoglobin binding assay as described
previously [26]. The concentrations of serum amyloid
were determined using an enzyme linked immunosorbent
assay kit (Tridelta Development PLC, Dublin, Ireland)
according to the manufacturer's instructions [26]. The
limits of detection of the haptoglobin and serum amyloid
A assays were 20 μg/ml and 0.33 μg/ml, respectively.
Table 1: Genebank accession numbers, product sizes and nucleotide sequence details of primers for RT-PCR analysis of mRNA 
expression of bovine TLR 1 to 10.
Gene Primer Sequence 5'>3' Product Size (bp) Accession No.
TLR1 Sense ACT TGG AAT TCC TTC TTC ACG A 176 NM_001046504
Anti-sense GGA AGA CTG AAC ACA TCA TGG A
TLR2 Sense GGT TTT AAG GCA GAA TCG TTT G 190 NM_174197
Anti-sense AAG GCA CTG GGT TAA ACT GTG T
TLR3 Sense GAT GTA TCA CCC TGC AAA GAC A 195 NM_001008664
Anti-sense TGC ATA TTC AAA CTG CTC TGC T
TLR4 Sense CTT GCG TAC AGG TTG TTC CTA A 153 NM_174198
Anti-sense CTG GGA AGC TGG AGA AGT TAT G
TLR5 Sense CCT CCT GCT CAG CTT CAA CTA T 172 AY634631
Anti-sense TAT CTG ACT TCC ACC CAG GTC T
TLR6 Sense CCT TGT TTT TCA CCC AAA TAG C 154 NM_001001159
Anti-sense TAA GGT TGG TCC TCC AGT GAG T
TLR7 Sense TCT TGA GGA AAG GGA CTG GTT A 205 DQ333225
Anti-sense AAG GGG CTT CTC AAG GAA TAT C
TLR8 Sense TAA CCT TCG GAA TGT CTC CAG T 232 NM_001033937
Anti-sense GTG GGA AAT TCT GTT TCG ACT C
TLR9 Sense CTG ACA CCT TCA GTC ACC TGA G 156 NM_183081
Anti-sense TGG TGG TCT TGG TGA TGT AGT C
TLR10 Sense ATG GTG CCA TTA TGA ACC CTA C 248 NM_001076918
Anti-sense CAC ATG TCC CTC TGG TGT CTA AReproductive Biology and Endocrinology 2008, 6:53 http://www.rbej.com/content/6/1/53
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Analysis
Comparisons between treatment groups were made using
ANOVA with Bonferroni Posthoc tests for normally dis-
tributed data, and Kruskal-Wallis tests for fold changes in
gene expression. Significance was attributed when P  <
0.05 and data are reported as mean ± SEM.
Results
Toll-like receptors
Gene transcripts for the ten mammalian TLRs were
detected in bovine endometrium (Fig. 1). The level of
expression did not differ significantly between whole
endometrium collected from the body of the uterus, or
the horn ipsilateral or contralateral to the corpus luteum.
Endometrium contains endothelial, immune and blood
cells, so the expression of TLRs was also examined in puri-
fied populations of epithelial and stromal cells, which
were free of immune cell contamination as determined by
the absence of mRNA for the pan-leukocyte marker CD45
(data not shown) [14]. Epithelial cells expressed TLRs 1 to
7 and 9; stromal cells expressed TLRs 1-4, 6, 7, 9 and 10
(Fig. 2).
E. coli is the first pathogen associated with uterine disease
after parturition, inducing prostaglandin E2 secretion by
epithelial cells [14]. So, a range of purified bacterial
PAMPs were used to test if the TLRs associated with detec-
tion of bacteria were functional. Epithelial cells secreted
more prostaglandin E2 than controls when treated with
LPS, Pam3CSK4, or LTA, but not bacterial DNA (Fig. 3a).
The PAMPs did not affect cell survival (Fig. 3b). The secre-
tion of prostaglandin E2 was maximal for the O55:B5 LPS
and this was greater than O111:B4 LPS (P < 0.05), so sub-
sequent experiments used O55:B5 E. coli LPS as the stand-
ard PAMP to challenge cells.
TLR 1 to 10 gene expression by bovine endometrium collected from the uterine body, and the uterine horn ipsilateral or con- tralateral to the ovary containing the corpus luteum (n = 3 per location) Figure 1
TLR 1 to 10 gene expression by bovine endometrium collected from the uterine body, and the uterine horn 
ipsilateral or contralateral to the ovary containing the corpus luteum (n = 3 per location). Also shown is GAPDH 
expression for comparison. RNA was isolated as described, and the resulting cDNA was analyzed by PCR for the presence of 
TLR gene transcripts using the primer pairs described in Table 1.
                        Horn 
     Ipsilateral             Contralateral         Body of Uterus  TLR 
1 
2 
3 
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GAPDH Reproductive Biology and Endocrinology 2008, 6:53 http://www.rbej.com/content/6/1/53
Page 6 of 12
(page number not for citation purposes)
Antimicrobial peptides
Gene transcripts for LAP, TAP, BNBD4 and DEFB5 (Fig.
4a) and a weak expression of BBD123 were identified in
epithelial cells by qRT-PCR, but there was no expression
of BBD119,  BBD120, BBD122, BBD122a, BBD124 and
BBD142. The stromal cells expressed LAP and TAP (Fig.
4a) but did not express BNBD4,  DEFB5,  BBD119,
BBD120, BBD122,  BBD122a, BBD123, BBD124 and
BBD142.
To test if LAP, TAP, BNBD4, DEFB5 or BBD123 were likely
to be important for the response to bacterial infection,
endometrial cells were challenged with LPS for 24 h.
Quantitative expression of LAP, TAP, BNBD4 and DEFB5
was increased relative to control in epithelial cells treated
with LPS (Fig 4b). However, the expression of LAP, TAP,
BNBD4 or DEFB5 was not significantly changed in epithe-
lial cells treated with LTA. In stromal cells treated with LPS
there was no consistent change in AMP gene expression,
but LTA reduced LAP expression (-2.39 fold relative to
control; P < 0.05) and increased TAP  expression (3.79
fold; P < 0.05). Progesterone (5 ng/ml) did not affect AMP
gene expression in epithelial or stromal cells (data not
shown).
Acute phase proteins
The concentrations of haptoglobin were below the detect-
able limit of the assay and the concentrations of serum
amyloid A just at the limit of detection for the test, with
no differences in APP concentrations between superna-
tants from control and LPS treated stromal or epithelial
cells.
MUC-1
Epithelial but not stromal cells expressed MUC-1 mRNA,
and treatment of epithelial cells with LPS increased the
expression of MUC-1 (Fig. 5). Luteal phase but not follic-
ular phase concentrations of ovarian steroids reduced
MUC-1 expression, although neither significantly affected
the MUC-1 expression in response to treatment with LPS
(Fig. 5).
Discussion
Bacterial infection of the female genital tract is common
in cattle particularly after parturition, causing considera-
ble disease, infertility and even mortality [2]. The
endometrium is the first line of defence against these bac-
teria. Key components of innate immunity are the recog-
nition of PAMPs by TLRs, leading to increased expression
of AMPs and APPs [11,15]. In the present study endome-
trial samples expressed TLRs 1 to 10, whilst purified pop-
ulations of epithelial cells expressed TLRs 1 to 7 and 9,
and stromal cells expressed TLRs 1 to 4, 6, 7, 9 and 10. The
TLRs appeared to be functional as epithelial cells secreted
prostaglandin E2 in response to bacterial PAMPs. In addi-
tion, the epithelial cells expressed AMPs, such as TAP and
LAP, which were increased when the cells were treated
with LPS. Although, there was no evidence of localised
secretion of APPs, the epithelial cells also expressed MUC-
1. It appears that the epithelial cells play a critical role in
the innate immune defence of the endometrium against
bacteria that cause infertility.
The observation that bovine endometrial tissue expressed
gene transcripts for all ten TLRs is similar to human
endometrium [27,28]. Human endometrial TLR expres-
sion is regulated in part by the stage of the cycle [28]. In
cattle, there is a progesterone concentration gradient
TLR 1 to 10 gene expression by bovine endometrial stromal and epithelial cells Figure 2
TLR 1 to 10 gene expression by bovine endometrial stromal and epithelial cells. Also shown is GAPDH expression 
for comparison. RNA was isolated as described, and the resulting cDNA was analyzed by PCR for the presence of TLR gene 
transcripts using the primer pairs described in Table 1. A representative result is shown (n = 3).
TLR  
 1      2      3       4       5       6      7      8      9      10 
Epithelium 
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Endometrial epithelial cell (a) secretion of prostaglandin E2 and (b) cells per ml after 24 h treatment with 1 μg/ml O55:B5 E. coli  LPS, 1 μg/ml ultrapurified O111:B4 E. coli LPS, 1 μg/ml Pam3CSK4, 1 μg/ml lipoteichoic acid (LTA) from Staphylococcus aureus,  or 5 μg/ml LPS-free E. coli DNA (n = 6) Figure 3
Endometrial epithelial cell (a) secretion of prostaglandin E2 and (b) cells per ml after 24 h treatment with 1 μg/
ml O55:B5 E. coli LPS, 1 μg/ml ultrapurified O111:B4 E. coli LPS, 1 μg/ml Pam3CSK4, 1 μg/ml lipoteichoic acid 
(LTA) from Staphylococcus aureus, or 5 μg/ml LPS-free E. coli DNA (n = 6). Values differ significantly from control, 
***P < 0.001, **P < 0.01.
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A Analysis of antimicrobial peptide mRNA by epithelial and stromal cells Figure 4
A analysis of antimicrobial peptide mRNA by epithelial and stromal cells. RNA was isolated as described, and the 
resulting cDNA was analyzed by RT-PCR for the presence of TAP, LAP, BNBD4 and DEFB5 gene transcripts as described in 
Materials and Methods. A representative result is shown (n = 3 epithelial, E1–3, and stromal samples, S1–3). B analysis of antimi-
crobial peptide mRNA expression by epithelial cells. Endometrial epithelial cells were stimulated with 1 μg/ml O55:B5 E. coli 
LPS for 24 h and harvested. TAP, LAP, BNBD4, DEFB5 and BBD123 mRNA was quantified as described in Materials and Methods, 
and the data presented as fold change relative to gene expression in control cells (n = 3) Values differ significantly from control, 
* P < 0.05.
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MUC1 gene expression by epithelial cells Figure 5
MUC1 gene expression by epithelial cells. Cells were stimulated for 24 h with 1 μg/ml O55:B5 E. coli LPS, luteal phase 
steroid concentrations (5 ng/ml progesterone; 0.3 pg/ml oestradiol) or follicular phase steroid concentrations (0.5 ng/ml pro-
gesterone, 3 pg/ml oestradiol) alone or in combination, as indicated. mRNA was quantified as described in Materials and Meth-
ods, and the data presented as fold change relative to gene expression in control cells (n = 3). Values differ significantly from 
control, * P < 0.05.
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across the uterus with the highest concentration at the tip
of the horn ipsilateral to the corpus luteum and the lowest
in the contralateral uterine horn [29]. Progesterone con-
centrations are important because progesterone sup-
presses immune defences in the bovine endometrium [9].
However, there were no obvious differences in gene tran-
script expression for any of the TLRs between different
locations in the uterus.
Endometrial tissue samples contain several cell types
including immune cells, so to test the concept that the
endocrine cells have a role in immunity, we explored TLR
expression in purified populations of epithelial and stro-
mal cells, which are free of immune cell contamination in
cattle [14]. The epithelial cell expression of TLRs 1 to 7
and 9, and stromal cells expression of TLRs 1 to 4, 6, 7, 9
and 10, is similar to humans, where expression of TLR 1
to 9 has been reported in endometrial cell lines and in pri-
mary uterine epithelial cell cultures [30,31]. The epithelial
cell expression of TLRs  1, 2, 4, 6 and  9  is important
because they are required to detect bacterial PAMPs [11].
Bacterial infection is the predominant cause of uterine dis-
ease in cattle, and E. coli paves the way for other pathogens
to cause damage to the endometrium, as well as disrupt-
ing endocrine function [5].
Bacterial PAMPs include LPS, LTA and DNA, so we tested
the effects of these and the synthetic Pam3CSK4, to gain
an insight into whether the cognate TLRs 1, 2, 4, 6 and 9
are functional in the epithelial cells. We chose to evaluate
prostaglandin E2  concentrations because it is a clear
marker of bacterial infection in the bovine endometrium,
as well as having an important endocrine role for regulat-
ing ovarian cycles and implantation [14,32]. E. coli or LPS
switches epithelial cell secretion from prostaglandin F2α to
predominantly prostaglandin E2, mediated by the TLR4,
MD2, CD14 signalling complex expressed by epithelial
cells [14]. The predominant secretion of prostaglandin E2
rather than prostaglandin F2α is dependent on bacteria or
PAMPs stimulating changes in the eicosaniod synthesis
pathway, which includes phospholipases and prostaglan-
din synthases (Herath, unpublished data). This switch in
function is important as prostaglandin F2α initiates luteol-
ysis whereas prostaglandin E2 is luteotrophic in ruminants
[33]. Prostaglandin E2 is also an important component of
the immune response to bacteria and regulates or sup-
presses inflammation in many tissues [34]. In the present
study, LPS, LTA and Pam3CSK4 increased prostaglandin
E2 secretion and none of the ligands affected epithelial cell
survival, extending earlier observations that LPS was
detected by human and bovine endometrial cells [14,35].
This stimulation of epithelial cell secretion of prostaglan-
din E2 by several bacterial PAMPs may explain the associ-
ation between uterine disease and extended luteal phases
[36,37]. The secretion of prostaglandin E2 was greater for
the LPS from O55:B5 than O111:B4 E. coli, which may
reflect the greater purity of the latter preparation. On the
other hand, the O55:B5 LPS provided a potent PAMP to
evaluate AMP expression in subsequent experiments.
The AMPs are an important arm of the innate immune
defence against bacteria and TLRs mediate their induction
in many mamalian tissues [15,38]. In the present study,
bovine endometrial epithelial cells expressed several
AMPs including LAP,  TAP,  BNBD4  and  DEFB5, whilst
stromal cells expressed mainly LAP and TAP. The predom-
inant expression of TAP and LAP by the epithelial cells is
similar to the bovine mammary gland [39]. In humans, β-
defensins have also been detected in the endometrium
(HBD1, 2, 3 and 4), although there are some differences
between studies [40,41]. In the present study, the epithe-
lial cell AMP expression appeared to be of functional
importance as the gene expression was increased in epi-
thelial cells treated with LPS. The epithelial cells were con-
sistently more responsive than the stromal cells, and LPS
stimulated a greater response than LTA. Similarly in
humans, endometrial HBD2  mRNA expression is
increased after 24 h treatment with LPS, although unlike
studies with human cells we did not find that progester-
one regulated AMP expression in endometrial cells
[40,41]. However, the substantial induction of epithelial
LAP  and  TAP  by LPS treatment probably reflects their
defensive role against E. coli in cattle, and agrees with the
concept that TLRs mediate induction of AMPs in response
to PAMPs [15].
The concentrations of APPs, including haptoglobin and
serum amyloid A, are substantially increased in the
peripheral plasma of cow with bacterial infection of the
endometrium [5]. Similar to the AMPs, the APPs such as
haptoglobin and serum amyloid A provide non-specific
protection against microbes [18]. Although usually pro-
duced by the liver, there is evidence of localised APP
expression in the genital tract of rodents, regulated by the
sex steroids [19,20]. However, in the present study the
concentrations of haptoglobin and serum amyloid A pro-
teins were barely detectable in epithelial or stromal cells,
and not affected by treatment of cells with LPS. In vivo
peripheral plasma concentrations are at least 25 times
those of the culture supernatants [42]. So, it appears
unlikely that localised secretion of APPs plays a major role
in endometrial immunity in cattle.
MUC-1 is a glycosylated transmembrane protein com-
monly expressed by the epithelial cells of mucosal sur-
faces, including the reproductive tract, gut, testis and
mammary gland [21,43]. MUC-1 is expressed in the
human and ovine endometrium and has important roles
in endometrial receptivity for embryo implantation, and
is a marker of endometrial health and fertility in humansReproductive Biology and Endocrinology 2008, 6:53 http://www.rbej.com/content/6/1/53
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[22,23]. However, like AMPs and APPs, MUC-1 also has a
role in protecting mucosal surfaces against bacteria. MUC-
1 sterically inhibits microbial access to the cell surface and
regulates inflammation [21,43]. In the present study,
MUC-1 expression was detected in the bovine epithelial
cells and LPS increased the mRNA expression. In the
human endometrium, MUC-1 is highly regulated by the
ovarian sex steroids [44]. Although luteal phase concen-
trations of ovarian steroids decreased MUC-1 expression,
follicular phase concentrations had no effect in the
present study. Further, neither steroid combination
affected the increase of MUC-1 expression stimulated by
LPS. This is in contrast to the reduction in LPS-stimulated
prostaglandin E2 secretion associated with progesterone
or oestradiol [14].
Conclusion
In conclusion, the endometrium is an important first line
of defence against invading bacteria that cause disease in
cattle and endometrial samples expressed TLRs 1 to 10.
The present study explored the concept that the endocrine
cells play an important mechanistic role in the defence of
the endometrium against bacteria. Purified populations
of endometrial epithelial cells expressed TLRs 1 to 7 and
9, and stromal cells expressed TLRs 1 to 4, 6, 7, 9 and 10.
The TLRs appear to be functional as epithelial cells
secreted prostaglandin E2 in response to bacterial PAMPs.
In addition, the epithelial cells expressed AMPs, such as
TAP and LAP, and MUC-1, which were upregulated when
the cells were treated with LPS. Thus, innate immune
defence systems in the epithelial cells of the bovine
endometrium are likely to play a key role in the preven-
tion of endometrial infection with bacteria and mediate
changes in endocrine function.
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